• EverGen renews offtake agreement at Fraser Valley Biogas that covers up to 190,000 gigajoules of RNG annually at more favorable pricing compared to original agreement
• Offtake marks key milestone that enables full funding of company’s Core RNG Expansion project at FVB and another step towards its target of 1,000,000 GJ of RNG per year
• Company partnered with Adelaide, investor relation firm with developed network of investors across North America and globally, to raise its visibility before expanded pool of investors as it prepares to embark on rapid expansion chapter in its growth trajectory

EverGen Infrastructure (TSX.V: EVGN) (OTCQX: EVGIF) has announced that its wholly owned subsidiary Fraser Valley Biogas Ltd. has signed a term sheet for a long-term RNG offtake agreement intended to replace the existing agreement as it approaches the end of the term (https://ibn.fm/rw136). As a legal contract in which a buyer agrees to purchase a certain amount of the product at set price points, offtakes are an essential tool for producers to secure a predictable revenue stream for the project and improve access to funding. The term sheet for the new deal, expected to cover the purchase of up to 190,000 gigajoules of RNG annually from FVB, is penned amid considerably stronger market pricing compared to when the facility initially started. This milestone supports full funding of EverGen’s Core RNG expansion project at FVB and marks an important step towards the company’s goal of 1,000,000 GJ of RNG per year from its core RNG expansion and development project portfolio. EverGen acquired Fraser Valley Biogas in 2021 and is currently working to enhance and expand the facility. Located in Abbotsford, BC, Fraser Valley Biogas, has been digesting manure and off-farm organics since 2011, combining anaerobic digestion and biogas upgrading to produce RNG, mainly by processing agricultural waste from local dairy farms. Known as the original producing RNG facility in Western Canada, it is also the first project to produce RNG into FortisBC’s network. “This marks another key milestone for EverGen and underpins our expansion at Fraser Valley Biogas,” said Chase Edgelow, CEO of EverGen. “Our Core RNG expansion projects are fully funded to deliver RNG production of nearly half a million GJ annually, using a solution that captures greenhouse gases to supply low-carbon energy, supporting the energy transition,” he concluded. As EverGen seeks to accelerate growth to achieve ambitious targets, it has partnered with Adelaide Capital, a major investor relations and capital markets advisory firm specializing in small and mid-cap companies, to provide investor relations and consulting services to the company. To respond to the new market reality, growing public companies often need investor relation partners to help them raise their visibility, create investor awareness, improve investor communication, and strengthen relationships with the broader investment community. Through its capital markets program, Adelaide – which prides itself on personal connections to a sizable network of investors across North America and globally – will assist EverGen in activities such as non-deal roadshows, virtual campaigns, conferences, and investor communication. The deal, which is to be approved by the company’s Board of Directors, involves a monthly fee of C$10,000, as well as 15,000 stock options at an exercise price of $2.75 per share and a three-year term. “We are thrilled to be working with Adelaide Capital, who will provide us with a comprehensive investor relations platform and help strengthen our communication with current and prospective shareholders as we pursue our next leg of growth,” said Chase Edgelow as he announced the partnership. Positioned as a leading RNG platform boasting a robust pipeline of projects with the potential to deliver significant RNG volumes and help Canada accelerate the energy transition, EverGen seeks to make a meaningful impact on both the industry and the environment. The company appears to have a strong position to expedite growth as the country’s RNG infrastructure platform as it remains committed to delivering on its ambitious goals for a more sustainable future. For more information, visit the company’s website at www.EvergenInfra.com. NOTE TO INVESTORS: The latest news and updates relating to EVGIF are available in the company’s newsroom at https://ibn.fm/EVGIF

• October declared National Clean Energy Action Month as government mobilizes toward a future powered by sustainable energy and a healthier environment for all
• Although clean energy momentum continues to build, not all green energy sources are created equal; some can still leave significant environmental impact
• GeoSolar seeks to demonstrate that living in carbon-powered homes is no longer necessary; offers homeowners renewable ways to generate electricity without greenhouse gas emissions

As the climate crisis threatens the safety and health of people worldwide, forcing countries to fight weather disasters such as floods, droughts and wildfires, governments around the world – the US included – recognize that the window to prevent devastating consequences is rapidly closing. But as the adage goes, there is opportunity in every crisis. Still, once a crisis is in full swing, turning it into an opportunity often calls for new ways of thinking and responding. That’s where companies like GeoSolar Technologies (“GST”) with its SmartGreen(TM) Home system can step in to help fight against one of the biggest existential challenges of our time by transforming how homeowners heat, cool, and power homes with 100% natural energy sources. “The climate crisis is here. Our Nation — and the world — sits at an inflection point. By investing in clean energy, modernizing our infrastructure, and ensuring that everyone benefits in the process, we can build a safer, healthier, and more energy-secure future,” President Biden said as he proclaimed October 2022 as National Clean Energy Action Month. To address this crisis, the US government has set an aspiring but achievable goal of reaching a 100% clean electricity sector by 2035 and net zero emissions economy-wide by no later than 2050. Actionable steps have been taken to make this formidable goal a reality, including establishing the first National Climate Task Force in history, reinstating, and enhancing environmental protections, and encouraging unprecedented private sector commitments to clean energy transition (https://ibn.fm/P2bBC). With the energy sector accounting for more than 80% of the country’s emissions, it is becoming increasingly clear that the progress toward this aggressive target for slashing the US share of global emissions will rely on tackling energy efficiency. Existing homes are a major cause of the climate crisis since home energy use accounts for one-sixth of total energy consumption in the US (https://ibn.fm/lmlkN). The most effective way to reduce home greenhouse gas emissions is to replace electricity generated from fossil fuels with low- and zero-carbon sources such as wind, solar and geothermal. For that, commitment to investment and innovation is required to bring cleaner energy and lower energy bills for homeowners and businesses. As the country strives to turn the climate crisis into opportunity, the government appears confident that the country can lead the world in producing and exporting clean energy technologies, lowering energy costs, and addressing environmental injustice. The climate crisis is a challenge desperately waiting to be addressed and the cost of the status quo is rising. But as the world continues to grapple with the consequences of climate change, what should not be overlooked is that not all renewable energy is created equal – even if an energy source or means of transport has a smaller carbon footprint, it can still leave a considerable climate footprint. One such example is Kennecott’s 100-year-old Bingham Copper Mine which is developing a new vein of ore in Utah, a state abundant in copper and other minerals essential to creating an electrified economy. While the benefits of a more electrified economy are today largely undisputed, Utahns may still wonder if they come with a high price tag, given that the mine is the state’s largest source of air pollution. Instead, more research efforts, capital investments, and suitable locations for solar, wind and geothermal generation may offer an alternative approach to tackling the climate crisis (https://ibn.fm/L3HmA). In infinite supply and with no or little greenhouse gas emissions, these energy sources are often considered greener as they can deliver more impactful decarbonization in the effort to reach net zero by 2050. With its SmartGreen(TM) Home system that combines solar power, geothermal ground-sourced energy, and other clean energy technologies into one fully integrated system, GeoSolar seeks to empower American homeowners with a cleaner, healthier, and cheaper way to power their homes compared to traditional carbon-based energy systems (https://ibn.fm/3dK0K). Built to replace outdated fossil fuel-driven energy systems, SmartGreen(TM) Home is designed to generate enough renewable energy to power homes without utility bills and drastically reduce their carbon footprint. Offering solutions developed with both conscience and convenience in mind, GeoSolar strives to create a healthier living environment with net zero-carbon homes at its core. For more information, visit the company’s website at www.GeoSolarPlus.com. NOTE TO INVESTORS: The latest news and updates relating to GeoSolar Technologies are available in the company’s newsroom at https://ibn.fm/GST

• Correlate Infrastructure Partners Inc. is a provider of environmentally friendly utilities use optimization solutions, utilizing proprietary data-driven analytics and industry expertise to improve outcomes
• CIPI recently formed a partnership with Ultra Yield Solutions (“UYS”) to support clients in the controlled environment agriculture (“CEA”) industry, such as vertical indoor growers
• Under the agreement, UYS will focus on cost-efficient LED lighting solutions while CIPI will deliver renewable energy options and financing opportunities to help make the indoor farming operation even more sustainable
• The global indoor farming market size is expected to reach $44.3 billion this year before growing to $122.3 billion by 2030 at a CAGR of 13.5 percent, with vertical farming comprising the fastest growing segment

Last month, the world’s largest indoor vertical farming operation opened in Pennsylvania with a 140,000-square-foot facility promising about 160 jobs and seven-day-a-week production (https://ibn.fm/AKwG3). The facility is likely to be a harbinger for the growth of indoor vertical farming practices, a subset of the farming technology-driven controlled environment agriculture (“CEA”) industry (https://ibn.fm/77Omd). A competing California company is already planning a larger facility in Virginia (https://ibn.fm/1SM6d). Indoor vertical farming favors leafy green horticulture, one reason it is seen as the modus operandi of the home industry for cannabis where personal use cultivation is legal, as well as the majority of commercial operations (https://ibn.fm/tjaQE). Regardless of the type of agriculture being cultivated, indoor operations are dependent on efficient light strategies to ensure success in a contained environment. Correlate Infrastructure Partners (OTCQB: CIPI) is a Louisiana-based clean energy solutions innovator dedicated to helping commercial operations effectively manage their utilities usage, both for the sake of their financial sheets as well as the resulting benefit to the global environment amid rising concerns about climate change. The company, also known as CIPI for short, recently announced an agreement with CEA lighting distributor Ultra Yield Solutions (“UYS”) to cooperatively sustain clients who need professional indoor farming lighting design, with UYS focusing on LED solutions and CIPI responding with renewable energy and financing solutions. “We are excited to see this partnership transform the CEA space by dramatically reducing the operating costs of urban indoor farming. It will enable operators to reach profitability faster while simultaneously increasing the sustainability and resilience of their businesses,” Correlate’s VP of Sales Jim Fiorentino stated in the Sept. 7 announcement (https://ibn.fm/1TTRl). “Partnering with Correlate allows us to give our CEA customers everything they need to drive operating costs down, improve sustainability and maximize crop yield,” UYS founder and Chairman Chris Brown added. “Because we can handle the entire process from design to development to funding, indoor farmers can now simply focus on what’s important: their crops.” Climate change concerns have drawn increasing awareness to severe weather trends worldwide and their effects on crop harvests. Commercial industries have seen a growing tendency toward transparency in the energy use and carbon emissions of their operations as an effort to show they are socially responsible, measuring the beneficial outcomes of their labors in terms of published environmental, social and governance (“ESG”) factors. Indoor growers are able to avoid many of the vagaries attributable to weather factors. AeroFarms, the company that opened the huge Pennsylvania facility last month, claims it will harvest 26 different crops using up to 95 percent less water than traditional farming and no pesticides, and will do so on a smaller footprint of land than it would need for outdoor harvesting (https://ibn.fm/37Hlo). Analysts at Grand View Research, Inc., reported the global indoor farming market size was valued at $39.5 billion last year and is expected to reach $44.3 billion this year before growing to $122.3 billion by 2030 at a CAGR of 13.5 percent (https://ibn.fm/on78V). The vertical farm segment is expected to be the fastest growing, with a CAGR of 22.9 percent. Such market factors portend a growing demand for cost-efficient and environmentally responsible lighting and energy use solutions such as those advanced by the CIPI and UYS partnership. For more information, visit the company’s website at www.CorrelateInfra.com, including the following:

• Breaking Down Barriers To Your ESG Goals While Generating Additional Net Operating Income: www.CorrelateInfra.com/our-process
• Platform Generates New Rent And Operating Income, Allowing You To Meet Your ESG Goals: www.CorrelateInfra.com/program

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI

• Hypertension affects nearly half of all adults in the United States – 47% or 116 million people, some of which are medication-resistant
• A recent study from the University of Toledo College of Medicine and Life Sciences concluded gut bacteria might be the cause of medication-resistant hypertension – as demonstrated in rats used to conduct the study
• Lexaria’s patented DehydraTECH(TM) technology offers a viable solution for hypertension drug administration and has been received favorably by the FDA during a pre-Investigational New Drug meeting

Hypertension, or high blood pressure, remains one of the world’s most deadly health problems, considered a silent killer because it presents with no symptoms. Nearly half of the adult population in the United States (47% or 116 million) have been diagnosed with hypertension, as defined by having systolic blood pressure greater than 130 mmHg or diastolic blood pressure greater than 80 mmHg or taking medication for the condition (https://ibn.fm/icRSu). Within this category of adults, some fall into a medication-resistant form of hypertension. A new study by The University of Toledo College of Medicine and Life Sciences has shown that gut bacteria may be a culprit for medication-resistant hypertension, solving an elusive mystery that has plagued many Americans and their physicians. The study, conducted using lab rats, concluded that a specific gut bacterium, Coprococcus, was responsible for breaking down the antihypertension medications quinapril and ramipril, resulting in compromised blood pressure-lowering effects. The study also cites a specific instance where a female with medication-resistant hypertension was administered antibiotics two weeks prior to a procedure. Her blood pressure lowered naturally – as the antibiotics depleted the gut bacteria. Although long-term antibiotics are not a viable solution for lowering blood pressure, the group has concluded that more research is necessary (https://ibn.fm/Do8tT). Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is on a mission to transform the way hypertension is treated through its patented technology, DehydraTECH(TM). DehydraTECH improves the bioavailability of pharmaceuticals and therapeutics in part by bypassing first-pass-liver processing. DehydraTECH also provides the following benefits:

• Masks unwanted tastes by eliminating the need for sugar-filled edibles
• Improves the speed of onset, with effects felt in minutes
• Increases bioavailability by more effectively delivering the drug into the bloodstream
• Increases brain absorption, with testing suggesting up to 10x improvement
• Reduces drug administration costs with a higher ratio of drug delivery

Lexaria’s ongoing research into DehydraTECH-CBD for the treatment of hypertension was received favorably by the FDA during the company’s pre-Investigational New Drug (pre-IND) meeting. The FDA agreed with Lexaria’s proposal to pursue a 505(b)(2) new drug application (“NDA”) regulatory pathway for its program. “We are very pleased to have received comments from the FDA toward opening our IND program. We will be executing FDA-confirmed IND-enabling work immediately,” said John Docherty, President of Lexaria (https://ibn.fm/w6Bva). “We were delighted that our proposals were very well received by the FDA, and the feedback received will be very helpful in compiling and filing our IND application as the next major regulatory step we are focused on moving forward.” The global antihypertension drug market was valued at $30.2 billion in 2021. This market is expected to grow at a CAGR of 3%, resulting in a valuation of $40 billion by 2031 (https://ibn.fm/5BQdY). The global CBD market was valued at $5.18 billion in 2021 and is expected to grow at a CAGR of 16.8%, resulting in a valuation of $22.05 billion by 2030 (https://ibn.fm/jpju5). Lexaria is leveraging both markets in its current pursuit of hypertension therapies and is positioned to penetrate through the use of its DehydraTECH technology – bringing about viable solutions to solve even the most medication-resistant hypertension through increased bioavailability and absorption of medication for this purpose. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• The UN has announced that the world is facing a global emergency, with up to 354 million people facing famine
• FuelPositive’s Green Ammonia Production System brings zero-carbon options to farms worldwide, offering an alternative means of supporting crops and farm equipment with lower energy costs and emissions
• The green ammonia market is expected to reach $5.48 billion by 2030 – driven by the need to adapt to lower emissions and the necessity to make agriculture more affordable

An announcement from the UN in mid-September issued the warning that the world is facing a global emergency of unprecedented magnitude – up to 345 million people are facing starvation, and 70 million are closer to starvation as a result of Russia’s war in Ukraine. Executive director of the UN’s World Food Program, David Beasley, told the Security Council that the number of people facing food insecurity in the 82 counties where the agency operates is two-and-a-half times the number of acutely food insecure people before the COVID-19 pandemic (https://ibn.fm/Vg5eU). Beasley further expressed concern that 50 million people in 45 countries are suffering from acute malnutrition and are “knocking on famine’s door.” Russia’s blockade of Ukrainian ports to bring Russian fertilizer back to global markets has exacerbated issues – driving up the cost of food and fuel worldwide. FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a company focused on licensing, partnership, and acquisition opportunities related to energy-efficient technologies and sustainability, is committed to providing commercially viable and sustainable clean energy solutions, including green ammonia, for use across a vast number of industries and applications. The opportunities for green ammonia are significant, with 80 percent of the world’s ammonia being used in the agricultural sector. FuelPositive’s on-farm alternative has the potential to significantly reduce the carbon dioxide emissions impacting the world due to the use of fertilizer in agricultural settings. The company’s green ammonia production system is a solution that decarbonizes and decentralizes the production of ammonia, providing farmers with the amount needed, when it is needed, and at stable pricing. FuelPositive’s system allows farmers to house green ammonia production on-site, the means to fertilize their crops, and power their internal combustion engines, generators, and other farm equipment more cost-effectively. Traditional fertilizer methods (manure) present environmental impacts like runoff of nitrogen-rich materials into waterways and water tables and cause significant detriment to air and water quality. Using deep injection of green ammonia cuts the emissions associated with manure. Still, the company acknowledges that more work is necessary to continue reducing the greenhouse gasses associated with ammonia and all nitrogen fertilizers. FuelPositive is committed to supporting best farming practices for emission reduction, which is crucial to its ability to fulfill a cradle-to-cradle commitment. Having already tackled the problem of carbon emissions in its product, the company is working with agricultural sector advisors to identify how to use its fertilizer in a way that results in the lowest amount of pollution possible. Pilot projects are in the planning stage with multiple scientists, working with leading Canadian universities. For more information, read the IPCC (Intergovernmental Panel on Climate Change) Report at https://ibn.fm/Xyx2x. Although the green ammonia market is still in the planning stages, it was valued at $36 million in 2021. The market is anticipated to grow at a CAGR of 74.78% from 2022 to 2030, resulting in a value of $5.48 billion. The driving factors of the industry’s growth can be attributed to the shift to zero-carbon emissions and the strict pollution rules with zero emission emphasis. By 2032, the green ammonia share of the overall market is anticipated to reach 3-4 percent, with a preference for green ammonia over traditional fertilizer methods (https://ibn.fm/BW7m2). For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

• REZYFi is a specialized financing company in the U.S., originating, structuring, and investing in first mortgage loans and alternative structured financings secured by commercial real estate properties
• Target markets include licensed and permitted cannabis companies, owners of real estate who lease to cannabis companies, and companies and individual homeowners seeking a variety of real estate-related first and additional mortgage-based financing
• Currently licensed in 36 states, with plans for expansion into all states, REZYFi is leveraging its experience, a network of independent brokers, and proprietary technology, to enhance its offering within target markets
• REZYFi operates through two wholly-owned subsidiaries – REZYFi Lending and ResMac, Inc. – offering financial services and direct lender/originator options across a large network of correspondents

The cannabis industry overall has been experiencing significant growth, with double-digit rates, and companies are competing to gain a significant market share. Leading players in the cannabis market are undertaking inorganic growth strategies, including expansions, investments, and acquisitions, to increase their profits and share of the market. The worldwide market is expected to be valued at $27.7 billion in 2022 and projected to reach $82.3 billion by 2027, recording a CAGR of 24.3%, driven by the increased legalization of cannabis for recreational and medical purposes use in countries (https://ibn.fm/8xmWf). Mortgage lender company REZYFi, servicing the needs of both traditional and non-traditional consumers and businesses, is positioned to be one of the first cannabis mortgage bankers in the United States – an industry where many traditional lenders are reticent to serve the state-licensed cannabis industry. REZYFi operates through two wholly-owned subsidiaries: REZYFi Lending – leveraging a wide network to offer options such as 15- and 30-year fixed-rate loans, FHA loans, VA loans, reverse mortgages, jumbo loans, and adjustable-rate mortgages, REZYFi Lending expects increased funding in marketing and loan agents to drive origination growth over the next two years, which is supported by its planned launch of a high-margin cannabis division later this year. ResMac, Inc. – in operation for 13 years, ResMac, Inc. allows REZYFi to operate as a direct lender and originator of residential mortgages, with active mortgage correspondent and mortgage servicing operations. ResMac primarily purchases and aggregates residential mortgages through its correspondent segment from trusted third-party originators. The subsidiary has closed more than 20,000 loans for more than 15,000 clients and expects to accumulate $285 million in retail origination in 2023. With its corporate strengths, REZYFi’s diversified approach to the real estate lending sector positions it to capitalize on growth in multiple verticals due to its experience, a network of independent brokers, and proprietary technology. Led by a seasoned management team, REZYFi has been built from the extensive experience of its leaders in real estate, financing subsectors, and the cannabis and hemp marketplace. Over the last five years, management has developed an extensive network of independent mortgage-related brokers and is currently training the network members on the company’s new service offerings, with many already launching new sales efforts. Currently licensed in 36 states, with plans to operate nationwide, REZYFi has invested heavily in designing, building, and implementing proprietary automated/machine learning technology to shorten loan processing timeframes and increase efficiencies. This allows the company to operate its legacy business at staffing levels meaningfully below its competitors. This unique advantage allows REZYFi to leverage its target markets and excel in areas where traditional banking institutions are still hesitant. For more information, visit the company’s website at www.REZYFi.com. NOTE TO INVESTORS: The latest news and updates relating to REZYFi are available in the company’s newsroom at https://ibn.fm/REZY

• Cannabis grower and product maker Flora Growth is developing its own approach to riding troubling economic forces, boasting a 604 percent YOY increase in the H1 reporting period this year
• Market analysts predict the global cannabis market’s value will rise during the next five years at a CAGR of 24.3 percent to arrive at annual valuation of $82.3 billion
• Flora Growth is levying the potential of recent cooperative agreements to increase the reach of its product distribution pipeline, including new exports to Switzerland, the Czech Republic and the United States
• Europe is predicted to be the fastest-growing region for cannabis sales during the next few years as a result of Europeans’ recognition of cannabis’ medical benefits and the ongoing advance of legalization

Cannabis cultivator, brand manufacturer and global distributor Flora Growth (NASDAQ: FLGC) is offering a bit of pain relief to economies battered by recent uncertainty over a costly worldwide pandemic, a war in Europe’s breadbasket and the retail supply chain disruptions that have resulted from them. The Canadian company with a productive base of operations in Colombia’s fertile greenbelt is licensed to cultivate cannabis on a 100-hectare (about 247-acre) farming facility and then deliver its product to its GMP-certified processing facility in the nation’s capital, where beauty, phytotherapeutic and nutraceutical products are prepared for market. And analysts foresee that market continuing to burst with opportunities. Reportlinker.com stated last month that it expects the global cannabis market to end the year with a valuation of $27.7 billion and to grow at a CAGR of 24.3 percent through 2027 to achieve $82.3 billion in sales at the conclusion of the next five years. Europe is expected to be the fastest-growing region. “The market in Europe is majorly driven by the awareness of medical benefits of cannabis in the region coupled with the healthcare system present in several European countries that covers the health expenditure of most patients in these regions. As the legalization of cannabis in European countries is at a nascent stage, this creates a considerable opportunity for companies to establish themselves in the region,” the report states (https://ibn.fm/EsfMY). Flora’s brand division is focused on developing plant-based consumer products, such as cannabinoid-infused juices, gummies, topicals, inhalables, and skin care. But the company also prioritizes the manufacture of “cannabinoid-derived medical formulations that can be sold domestically and internationally” (https://ibn.fm/iLRtv). In September, the company announced that it had completed its first exports of high-CBD dried cannabis flower to Switzerland and the Czech Republic and of CBD isolate to the United States. “We are proud to help increase access to safe, legal CBD and THC to consumers all over the globe,” Flora Growth Chairman and CEO Luis Merchan stated at the time (https://ibn.fm/BGNc5). “We look forward to working closely with our partners in Europe and North America to bring high-quality Colombian cannabis products and raw materials to market.” Flora has pursued acquisitions and partnerships that will help its distribution supply chain grow. Two recent examples include the receipt of about 75 SKUs from the No Cap Hemp Co. brand and a collaboration with Colombia’s Misak indigenous tribe’s pharmaceutical arm to speed up the fulfillment of company cannabis exports by taking advantage of the tribe’s approved license for medicinal and scientific use cannabis. The agreements are helping Flora to effectively improve its profitability through overhead management and vigilance in regard to working capital. “With all three of our core pillars generating revenue in the second half of 2022 … we believe we have a path to profitability that few global cannabis companies can achieve in this difficult environment,” Merchan stated in August (https://ibn.fm/kAshT). For more information, visit the company’s website at www.FloraGrowth.com. NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

• Reklaim appears poised to capitalize on new market opportunities for companies with a competitive edge in compliant data; it seeks to position itself as the go-to privacy-compliant data partner
• Shifting data-protection regulations and stricter privacy policies of Big Tech companies like Apple and Google require brands to replace their existing data suppliers with those compliant with new privacy standards
• Reklaim’s platform allows consumers to claim control of their personal data while brands can buy and sell consumer-consented privacy-compliant data

As the era of online tracking and monetizing consumer data without explicit consent is coming to an end, companies like Reklaim (TSX.V: MYID) (OTCQB: MYIDF) that provide consumer data compliant with government regulations are set to benefit in this rapidly evolving environment. Driven by the transformation of consumer privacy regulations and how Big Tech has adapted to this changing consumer sentiment and legislation, Reklaim appears poised to position itself as the go-to solution for businesses under swelling pressure to find a partner to solve this compliance gap. In an increasingly noisy digital environment, brands rely on consumer data for targeted marketing to better personalize their online presence to match their intended audience’s preferences. Until recently, so-called Big Tech companies – such as Facebook, Google, Amazon, and the like – were collecting immense amounts of personal information about consumers and selling it to the highest bidder without consumers’ knowledge or explicit consent. But under the pressure of changing regulations, the $400-billion data market is about to transform (https://ibn.fm/VLsQZ). As companies like Apple and Google align their products with the shifting regulation, making tracking consumers’ online behavior more challenging, digital data monetization becomes much more complicated. As a result, a drastic reduction in reliable data supply is expected. “The global data market has historically been built on collecting data unbeknownst to consumers and arbitraging it to as many different firms as possible for as much money as possible,” said Neil Sweeney, founder and CEO of Reklaim (https://ibn.fm/V1KgW). “This is quickly coming to an end, not only with accelerating changes in privacy legislation but also in how companies such as Google and Apple are quickly reducing the amount of data leaking from their products.” With the days of cookies and retargeting ads gone, brands are forced to rethink their marketing strategy – and access to consumer-consented data purchased from a compliant supplier with scale is deemed the critical step towards advertising in the modern, privacy-first world. With access to over 320 million profiles in the US alone, Reklaim emerges as a partner that can respond to these privacy challenges (https://ibn.fm/dBvk9). Its unique data platform serves consumers and brands alike. The company prides itself on being the world’s only company providing consumers with access to the digital information companies collected about them and guaranteed weekly monetization. They can view, edit, opt out, or be compensated when businesses use their data. At the same time, the platform allows brands and companies to buy and sell consumer-consented, privacy-compliant data. Considered an industry leader amid a growing broader trend that still goes largely unnoticed as the US is slowly but surely shifting toward a federally driven privacy policy, the company’s vision seems to be coming to fruition. After decades-long efforts to pass a law to protect Americans’ data privacy, a bipartisan draft bill recently released by key Congressional leaders indicates that a patchwork of state and sector-specific data privacy laws is about to be replaced by a comprehensive federal consumer privacy framework (https://ibn.fm/rhTbS). This modern world of privacy-protected data opens new opportunities for companies with a competitive edge in privacy-compliant data. As businesses re-evaluate their data suppliers over the next 12 months, Reklaim reveals plans to explore strategic M&A opportunities involving data partners that struggle with compliance issues amid the rapidly changing privacy market. As times are changing and consumers demand better protection of their online privacy, Reklaim appears well positioned to benefit from the emerging privacy landscape in which brands must have a reliable partner to ensure privacy-compliant data authorized by consumers. For more information, visit the company’s website at www.ReklaimYours.com. NOTE TO INVESTORS: The latest news and updates relating to MYIDF are available in the company’s newsroom at https://ibn.fm/MYIDF

• CO2 concentrations in the atmosphere are at the highest of the modern record era
• EverGen develops and operates renewable natural gas projects that significantly reduce pollutants like CO2 and methane
• With major customers and partners, EverGen has expanded from a single facility in British Columbia to a series of projects across Canada

Natural gas prices are soaring around the world, partly contributing to the inflation in Europe that has risen to a record 10% in September. At the same time, citizens in New Jersey gripe over state regulators approving natural gas rate hikes that went into effect Saturday ahead of the cold weather season. While prices rise and all eyes are on natural gas, the climate change debate rages on. Throwing fuel into the fire, a special supplement to the bulletin of the American Meteorological Society that was released in August, paints an eye-popping picture of the level of carbon dioxide (“CO2”) in the atmosphere. Decarbonization isn’t easy, but thankfully, there are companies like EverGen Infrastructure (TSX.V: EVGN) (OTCQX: EVGIF) that are rising to the challenge to provide RNG solutions for utilities who are increasingly looking to reduce the world’s dependence on fossil fuels and slash pollution. According to the report, CO2 concentrations increased 2.6 parts per million in 2021 from 2020, the fifth-higher growth rate since the start of the instrumental record in 1958. The increase pushed CO2 concentration in the atmosphere to the highest of the modern record era and ice core records dating back 800,000 years. Not to be left out, methane (“CH4”) concentrations in 2021 were also at a record high. Methane comes from a variety of anthropogenic and natural sources, such as landfills, oil and natural gas systems, and agricultural activities, amongst other things. There are emerging technologies (i.e., low-carbon hydrogen, carbon capture, utilization, and storage) to neutralize the environmental effect of natural gas that will be available in the future. In the meantime, companies and utilities are increasingly turning to RNG, also called biogas, as an option to natural gas extracted from the Earth. RNG is produced from decomposing organic waste from landfills, agricultural waste, and wastewater from treatment facilities. The process includes using anaerobic (devoid of oxygen) digestors to break down waste to produce biogas and digestate. The biogas is purified and used for heat and electricity or as biomethane for the natural gas grid or for powering vehicles. Digestate puts to use captured nutrients like nitrogen and phosphorus, using it for products such as fertilizer and livestock bedding. Not only is the waste used productively for sustainable products, but usage as feedstock also prevents natural decomposition in landfills or storage ponds, meaning significant levels of methane are kept from being released into the atmosphere. Climate change awareness has consumers, regulators and companies alike clamoring about implementing sustainable alternatives to natural gas, driving demand for RNG. This benefits EverGen, which has contracts with utilities and municipalities to produce and sell its RNG. EverGen was initially focused within its home province of British Columbia, where it owns three projects – Fraser Valley Biogas, Net Zero Waste Abbottsford, and Sea to Sky Soils – before it began expanding eastward across the country. The company is amid an expansion at Fraser Valley Biogas that will double RNG production to ~160,000 gigajoules (“GJ”) per year as part of a longer-term strategy to reach 1,000,000 GJ. EverGen’s projects are all structured via long term offtake agreements, and they already have a buyer who has been eagerly looking for new RNG supply. As testament to this, last week, EverGen signed a term sheet for a long-term offtake agreement that would replace and expiring agreement for RNG production at Fraser Valley. Pursuant to the new terms, the buyer commits to purchasing up to 190,000 GJ annually from the facility. To the east, EverGen has a 67% stake in GrowTEC, a multi-faceted bioenergy venture located on the Perry Family farm outside Lethbridge, Alberta that includes and operating biogas facility. The facility is slated to be modified to produce RNG that will be sold to FortisBC and tied into the local pipeline network. FortisBC is bullish on RNG, using it as part of its initiative to make a minimum of 15% of its gas supply carbon neutral by 2030. Most recently, EverGen acquired a 50% interest in Project Radius, a late-development stage portfolio of three high-quality RNG projects that will serve as the foundation of EverGen’s portfolio in Ontario. This project will cement EverGen’s position in the populous province that has copious amounts of organic feedstock. Collectively, the RNG output at the projects is estimate at 1,700,000 GJ annually. For more information, visit the company’s website at www.EvergenInfra.com. NOTE TO INVESTORS: The latest news and updates relating to EVGIF are available in the company’s newsroom at https://ibn.fm/EVGIF

• The concussion controversy surrounding Tua Tagovailoa has prompted both the NFL and the NFLPA to revisit the league’s concussion protocol in a move designed to enhance player safety
• In the wake of this controversy, Odyssey is emphasizing the potential value of its PRV-002 novel compound for the treatment of concussions and the benefit of the players
• According to a report published by Vox, there are approximately 0.41 concussions per NFL game in American football, with 9.3% of concussions involving the loss of consciousness and 2.4% resulting in hospitalizations
• With such cases, there is a need to revise the NFL’s concussion protocol and push for a treatment option that is effective in the treatment of this condition
• Odyssey is at the forefront of a possible pharmaceutical treatment option, as it advances its clinical trials, to potentially receive FDA approval

Odyssey Health (OTC: ODYY) is looking to push its PRV-002 novel compound for the treatment of concussions given the National Football League (“NFL”) and National Football League Players Association’s (“NFLPA”) joint announcement on changes to the league’s concussion protocol (https://ibn.fm/LOjTi). As a medical technology company focused on developing lifesaving medical products that offer technological and clinical advantages over current standards of care, Odyssey recognizes the severity of concussions, especially in the NFL. In addition, it acknowledges the ineffectiveness of current treatment options available for patients. The Tua Tagovailoa concussion controversy has prompted the NLF and the NFLPA to revisit the league’s concussion protocol, citing a dire need to “enhance player safety.” On September 25, Tagovailoa was checked for a concussion, but the neurotrauma consultant responsible for the check made “several mistakes” in his evaluation, according to multiple reports. The Dolphins quarterback sustained a hit in the Week 3 game, but the team reported that he passed concussion protocols. On Thursday, September 29, he suffered another injury following a similar tackle, leaving him with head and neck injuries, coupled with a confirmed concussion which resulted in a trip to the hospital. The injuries following the second incident raised significant concerns and backlash, with many arguing that Tagovailoa should not have played and was in danger of serious injury. This led to the launch of an investigation, which is still ongoing. It has so far led to the termination of the neurotrauma consultant who checked Tagovailoa on September 25. On September 28, Odyssey announced the completion of all cohorts for its Phase I Single Ascending Dosing (“SAD”) and Multiple Ascending Dosing (“MAD”) clinical trial for its PRV-002 novel compound for concussion treatment. The drug proved safe and well tolerated throughout the trial, paving the way for the next phase of its clinical trial (https://ibn.fm/1puyq). PRV-002 has been shown to significantly improve both neuroscore and memory score following injury in rats subjected to concussion models. While it is yet to receive approval from the United States Food and Drug Administration (“FDA”), this compound has shown significant potential in pre-clinical studies treating concussions, going above and beyond what current alternatives in the market offer. A 2020 report published by Vox noted that American football has approximately 0.41 concussions per NFL game. The study also pointed out that 9.3% of concussions involve loss of consciousness, and 2.4% result in hospitalizations (https://ibn.fm/DAFZE). With such cases, there is a need to revise the NFL’s concussion protocol to guarantee the safety of players. There is also an urgency to push for a treatment option that effectively treats the condition. Odyssey is at the forefront of pushing a novel treatment as it advances its clinical trials with the ultimate objective of receiving FDA approval. For more information, visit the company’s website at www.OdysseyHealthInc.com. NOTE TO INVESTORS: The latest news and updates relating to ODYY are available in the company’s newsroom at https://ibn.fm/ODYY